Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Reduction of parasitism tissue by treatment of mice chronically infected with Trypanosoma cruzi with lignano lactones (2010)

  • Authors:
  • USP affiliated authors: BASTOS, JAIRO KENUPP - FCFRP ; ALBUQUERQUE, SÉRGIO DE - FCFRP
  • USP Schools: FCFRP; FCFRP
  • DOI: 10.1007/s00436-010-1885-z
  • Subjects: DOENÇA DE CHAGAS (TRATAMENTO); FÁRMACOS
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    DOI or search this record in
    Informações sobre o DOI: 10.1007/s00436-010-1885-z (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Informações sobre o Citescore
  • Título: Parasitology Research

    ISSN: 0932-0113

    Citescore - 2017: 2.46

    SJR - 2017: 0.991

    SNIP - 2017: 1.001


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FCFRP2179833pcd 2179833 estantes deslizantes
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      ESPERANDIM, Viviane Rodrigues; FERREIRA, Daniele da Silva; SARAIVA, Juliana; et al. Reduction of parasitism tissue by treatment of mice chronically infected with Trypanosoma cruzi with lignano lactones. Parasitology Research, Heidelberg, v. 107, n. 3, p. 525-530, 2010. DOI: 10.1007/s00436-010-1885-z.
    • APA

      Esperandim, V. R., Ferreira, D. da S., Saraiva, J., Silva, M. L. A. e, Costa, E. S., Pereira, A. C., et al. (2010). Reduction of parasitism tissue by treatment of mice chronically infected with Trypanosoma cruzi with lignano lactones. Parasitology Research, 107( 3), 525-530. doi:10.1007/s00436-010-1885-z
    • NLM

      Esperandim VR, Ferreira D da S, Saraiva J, Silva MLA e, Costa ES, Pereira AC, Bastos JK, Albuquerque S de. Reduction of parasitism tissue by treatment of mice chronically infected with Trypanosoma cruzi with lignano lactones. Parasitology Research. 2010 ; 107( 3): 525-530.
    • Vancouver

      Esperandim VR, Ferreira D da S, Saraiva J, Silva MLA e, Costa ES, Pereira AC, Bastos JK, Albuquerque S de. Reduction of parasitism tissue by treatment of mice chronically infected with Trypanosoma cruzi with lignano lactones. Parasitology Research. 2010 ; 107( 3): 525-530.

    Referências citadas na obra
    Arantes RME, Marche HHF, Baha MT, Cunha FQ, Rossi MA, Silva JS (2004) Interferon-g-induced nitric oxide causes intrinsic intestinal denervation in Trypanosoma cruzi-infected mice. Am J Pathol 164:1361–1368
    Bastos JK, Gottlieb OR, Sarti SJ, Santos Filho D (1996) The isolation of lignans and sesquiterpenoids from leaves of Zanthoxylum naranjillo. Nat Prod Lett 9:65–70
    Bastos JK, Albuquerque S, Silva MLA (1999) Evaluation of the trypanocidal activity of lignans isolated from the leaves of Zanthoxylum naranjillo. Planta Med 65:1–4
    Bastos JK, Carvalho JCT, Souza GHB, Pedrazzi AHP, Sarti SJ (2001) Anti-inflammatory activity of cubebin, a lignan from the leaves of Zanthoxyllum naranjillo Griseb. J Ethnopharmacol 75:279–282
    Braga MS, Lauria-Pires L, Arganaraz ER, Nascimento RJ, Teixeira AR (2000) Persistent infections in chronic Chagas' disease patients treated with anti-Trypanosoma cruzi nitroderivatives. Rev Inst Med Trop 42:157–161
    Buckner FS, Verlinde CLMJ, La Flamme AC, Van Voorhis WC (1996) Efficient technique for screening drugs activity against Trypanosoma cruzi using parasites expressing b-galactosidase. Antimicrob Agents Chemother 40:2592–2597
    Cançado JR (2002) Long term evaluation of etiological treatment of Chagas disease with benznidazole. Rev Inst Med Trop 44:29–37
    Castro JA, de Mecca MM, Bartel LC (2006) Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis). Hum Exp Toxicol 25:471–479
    da Silva R, de Souza GH, da Silva AA, de Souza VA, Pereira AC, Royo Vde A, E Silva ML, Donate PM, de Matos Araujo AL, Carvalho JC, Bastos JK (2005) Synthesis and biological activity evaluation of lignan lactones derived from (−)-cubebin. Bioorg Med Chem Lett 15:1033–1037
    de Souza VA, da Silva R, Pereira AC, Royo Vde A, Saraiva J, Montanheiro M, de Souza GH, da Silva Filho AA, Grando MD, Donate PM, Bastos JK, Albuquerque S, e Silva ML (2005) Trypanocidal activity of (−)-cubebin derivatives against free amastigote forms of Trypanosoma cruzi. Bioorg Med Chem Lett 15:303–307
    Dias JC, Prata A, Correia D (2008) Problems and perspectives for Chagas disease control: in search of a realistic analysis. Rev Soc Bras Med Trop 41:193–196
    Dost CK, Saraiva J, Zentgraf U, Monesi N, Engels W, Albuquerque S (2006) Is nitric oxide involved in the tolerance of Calomys callosus as a reservoir host towards Trypanosoma cruzi infection? J Infect 52:49–55
    Esperandim VR, da Silva Ferreira D, Toldo MP, Saraiva J, Augusto MB, de Albuquqerque S (2010) New method quantification of Trypanosoma cruzi in animal’s tissue in the chronic phase of experimental Chagas’ disease. Parasitol Res DOI: 10.1007/s00436-010-1780-7
    Ferreira HO (1990) Treatment of the undetermined form of Chagas disease with nifurtimox and benznidazole. Rev Soc Bras Med Trop 23:209–211
    Garcia SB, Paula JS, Giovannetti GS, Zenha F, Ramalho EM, Zucoloto S (1999) Nitric oxide is involved in the lesions of the peripheral autonomic neurons observed in the acute phase of experimental Trypanosoma cruzi infection. Exp Parasitol 93:191–197
    Garcia S, Ramos CO, Senra JFV, Vilas-Boas F, Rodrigues MM, Campos-de-Carvalho AC, Ribeiro-Dos-Santos R, Soares MB (2005) Treatment with benznidazole during the chronic phase of experimental CD decreases cardiac alterations. Antimicrob Agents Chemother 49:1521–1528
    Heleno VCG, da Silva R, Pedersoli S, Albuquerque S, Bastos JK, e Silva MLA, Donate PM, da Silva GVJ, Lopes JLC (2006) Detailed 1H and 13C NMR structural assignment of three biologically active lignan lactones. Spectrochim Acta Part 63:234–239
    Jannin J, Villa L (2007) An overview of Chagas disease treatment. Mem Inst Oswaldo Cruz 102:95–97
    Lauria-Pires L, Braga MS, Vexenat AC, Nitz N, Simões-Barbosa A, Tinoco DL, Teixeira AR (2000) Progressive chronic Chagas heart disease ten years after treatment with anti-Trypanosoma cruzi nitroderivatives. Am J Trop Med Hyg 63:111–118
    Saraiva J, Veja C, Rolon M, da Silva R, e Silva MLA, Donate PM, Bastos JK, Gomez-Barrio A, de Albuquerque S (2007) In vitro and in vivo activity of lignan lactones derivatives against Trypanosoma cruzi. Parasitol Res 100:791–795
    Soares MB, Pontes-De-Carvalho L, Ribeiro-Dos-Santos R (2001) The pathogenesis of Chagas' disease: when autoimmune and parasite-specific immune responses meet. An Acad Bras Cienc 73:547–559
    Souza GH, da Silva Filho AA, de Souza VA, Pereira AC, Royo Vde A, e Silva ML, da Silva R, Donate PM, Carvalho JC, Bastos JK (2004) Analgesic and anti-inflammatory activities evaluation of (−)-O-acetyl, (−)-O-methyl, (−)-O-dimethylethylamine cubebin and their preparation from (−)-cubebin. Farmaco 59:55–61
    Suasnábar DF, Arias E, Streiger M (2000) Evolutive behavior towards cardiomyopathy of treated (nifurtimox or benznidazole) and untreated chronic Chagasic patients. Rev Inst Med Trop 42:99–110
    Toledo MJO, Bahia MT, Veloso VM, Carneiro CM, Machado-Coelhp GLL, Alves CF, Martins HR, Cruz RE, Tafuri WL, Lana M (2004) Effects of specific treatment on parasitological and histopathological parameters in mice infected with different Trypanosoma cruzi clonal genotypes. J Antimicrob Chemother 53:1045–1053
    Viotti R, Vigliano C, Armenti H, Segura E (1994) Treatment of chronic Chagas’ disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up. Am Heart J 127:151–162
    Viotti R, Vigliano C, Lococo B, Alvarez MG, Petti M, Bertocchi G, Armenti A (2009) Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities Expert. Rev Anti Infect Ther 7:157–163
    World Health Organization, Reporte del grupo de trabajo científico sobre la enfermedad de Chagas (2005) Actualizado en julio de 2007, Buenos Aires, Argentina, Document TDR/SWG/09
    Zhang L, Tarleton RL (1999) Parasite persistence correlates with disease severity and localization in chronic Chagas’ disease. J Infect Dis 180:480–486